{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:36:28Z","timestamp":1793086588684,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jneuroim.2017.08.010","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T15:31:17Z","timestamp":1504193477000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Neurobehavioral outcomes in autoimmune encephalitis"],"prefix":"10.1016","volume":"312","author":[{"given":"Anusha K.","family":"Yeshokumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Gordon-Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Arenivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Probasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2017.08.010_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ridd.2016.12.003","article-title":"Vineland-II adaptive behavior profile of children with attention-deficit\/hyperactivity disorder or specific learning disorders","volume":"61","author":"Balboni","year":"2017","journal-title":"Res. Dev. Disabil."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.08.010_bb0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jneuroim.2017.08.010_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2017.08.010_bb0020","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s11136-016-1386-3","article-title":"HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)","volume":"25","author":"Carlozzi","year":"2016","journal-title":"Qual. Life Res."},{"issue":"Pt 8","key":"10.1016\/j.jneuroim.2017.08.010_bb0025","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jneuroim.2017.08.010_bb0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2016.07.035","article-title":"PatientsLikeMe\u00ae online epilepsy community: patient characteristics and predictors of poor health-related quality of life","volume":"63","author":"de la Loge","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0040","article-title":"Home exercise programmes supported by video and automated reminders compared with standard paper-based home exercise programmes in patients with stroke: a randomized controlled trial","author":"Emmerson","year":"2016","journal-title":"Clin. Rehabil."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.08.010_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","article-title":"Cognitive deficits following anti-NMDA receptor encephalitis","volume":"83","author":"Finke","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2017.08.010_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.23932","article-title":"Functional and structural brain changes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"74","author":"Finke","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.08.010_bb0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2017.08.010_bb0060","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/jir.12303","article-title":"Longitudinal trajectories of intellectual and adaptive functioning in adolescents and adults with Williams syndrome","volume":"60","author":"Fisher","year":"2016","journal-title":"J. Intellect. Disabil. Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.08.010_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann. Neurol."},{"issue":"15","key":"10.1016\/j.jneuroim.2017.08.010_bb0070","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.2014.11100","article-title":"Patient-centered outcomes research institute. The PCORI perspective on patient-centered outcomes research","volume":"312","author":"Frank","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/0883073817720340","article-title":"Comparative outcomes in children and adults with anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis","author":"Gordon-Lipkin","year":"2017","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.08.010_bb0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jneuroim.2017.08.010_bb0085","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jneuroim.2017.08.010_bb0090","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10072-015-2089-1","article-title":"Engagement in a program promoting lifestyle modification is associated with better patient-reported outcomes for people with MS","volume":"36","author":"Hadgkiss","year":"2015","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jneuroim.2017.08.010_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166218","article-title":"Patient-reported treatment satisfaction with rivaroxaban for stroke prevention in atrial fibrillation. A French observational study, the SAFARI Study","volume":"11","author":"Hanon","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0100","series-title":"Adaptive Behavior Assessment System, Third Edition (ABAS-3)","author":"Harrison","year":"2015"},{"issue":"10","key":"10.1016\/j.jneuroim.2017.08.010_bb0105","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jneuroim.2017.08.010_bb0110","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1097\/JNN.0b013e31828a4161","article-title":"The impact of a patient support program for multiple sclerosis on patient satisfaction and subjective health status","volume":"45","author":"Kohlmann","year":"2013","journal-title":"J. Neurosci. Nurs."},{"issue":"18","key":"10.1016\/j.jneuroim.2017.08.010_bb0115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.0000000000002635","article-title":"Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort","volume":"86","author":"Lee","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2017.08.010_bb0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.08.010_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome","volume":"10","author":"Lim","year":"2014","journal-title":"J Clin Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2017.08.010_bb0130","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00415-014-7408-6","article-title":"Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity","volume":"261","author":"Malter","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parkreldis.2016.09.025","article-title":"Cognitive impairment in Parkinson's disease: association between patient-reported and clinically measured outcomes","volume":"33","author":"Mills","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.08.010_bb0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12028-015-0196-8","article-title":"Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes","volume":"24","author":"Mittal","year":"2016","journal-title":"Neurocrit. Care."},{"issue":"23","key":"10.1016\/j.jneuroim.2017.08.010_bb0145","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1212\/WNL.0000000000003409","article-title":"Feasibility of the collection of patient-reported outcomes in an ambulatory neurology clinic","volume":"87","author":"Moura","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yebeh.2016.08.019","article-title":"PARADISE 24 instrument: an observational study on psychosocial difficulties, quality of life, and disability levels in patients with epilepsy","volume":"64","author":"Quintas","year":"2016","journal-title":"Epilepsy Behav."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2017.08.010_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.08.010_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000001190","article-title":"The spectrum of acute encephalitis: causes, management, and predictors of outcome","volume":"84","author":"Singh","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2017.08.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3412","article-title":"Neurobehavioral outcomes in children after out-of-hospital cardiac arrest","volume":"137","author":"Slomine","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jneuroim.2017.08.010_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00325481.2016.1120162","article-title":"Loss of mobility and the patient burden of multiple sclerosis: expert opinion on relevance to daily clinical practice","volume":"128","author":"Smrtka","year":"2015","journal-title":"Postgrad. Med."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.08.010_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.parkreldis.2016.09.015","article-title":"Reliability and validity of a new dexterity questionnaire (DextQ-24) in Parkinson's disease","volume":"33","author":"Vanbellingen","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s11689-016-9175-4","article-title":"Associations between social cognition, skills, and function and subclinical negative and positive symptoms in 22q11.2 deletion syndrome","volume":"8","author":"Vangkilde","year":"2016","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.jneuroim.2017.08.010_bb0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2016.07.023","article-title":"Acute management of stroke patients taking non\u2013vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: design and rationale","volume":"182","author":"Xian","year":"2016","journal-title":"Am. Heart J."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817302746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817302746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:36Z","timestamp":1759048176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817302746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":38,"alternative-id":["S0165572817302746"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.08.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobehavioral outcomes in autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}